Clopidogrel - Kyungdong Pharm

Drug Profile

Clopidogrel - Kyungdong Pharm

Alternative Names: Inhiplat Tab.

Latest Information Update: 27 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kyungdong Pharm
  • Class 2 ring heterocyclic compounds; Antiplatelets; Chlorobenzenes; Esters; Pyridines; Small molecules; Thienopyridines
  • Mechanism of Action Platelet ADP receptor antagonists; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Acute coronary syndromes; Myocardial infarction; Peripheral arterial disorders; Stroke

Most Recent Events

  • 27 Jul 2016 Chemical structure information added
  • 20 Jul 2016 Clinical trials in Acute coronary syndromes in South Korea (PO)
  • 20 Jul 2016 Clinical trials in Myocardial infarction in South Korea (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top